text:  H226 Cisplatin treated, biological replicate 1 H226 Cisplatin treated cell line: H226; cell type: Squamous Cell Carcinoma (SCC); cisplatin phenotype: sensitive; treated with: cisplatin IC50 doses for 8 hrs